Sleeplessness after heart attack procedures and later health outcomes
Looks at new insomnia's effect on outcomes in adults after heart attack procedures.
Key facts
- Who runs it
- Samsung Medical Center
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction
- Status
- Not yet recruiting
- People taking part
- 235,342 people, planned
- Started
- 12 Feb 2026
- Planned end
- 30 Jun 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Insomnia medication
- No insomnia medication
- Record updated
- 18 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a heart attack and had a stent procedure (PCI) or bypass surgery (CABG). It studies how new sleep problems (insomnia) afterwards affect long-term health, using Korean health insurance records.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Acute myocardial infarction (heart attack).
- Earlier treatment
- Must be having percutaneous coronary intervention (opening the heart artery with a tube, often a stent) or coronary artery bypass surgery.
Main reasons for not taking part
- Mental health (psychiatric) disorders before the heart attack
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Diagnosis of acute myocardial infarction
- Undergoing percutaneous coronary intervention or coronary artery bypass surgery
Who cannot take part
- Pre-existing phychiatric disorders
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The present study aimed to evaluate the impact of acute insomnia on long-term clinical outcomes in patients underwent PCI or CABG for AMI using the Korean National Health Insurance Service (NHIS) database, and to identify the factors through which insomnia contributes to prognostic determination in this patient population.
The 2 groups in the trial
- No insomina
patient did not have insomia
- Insomnia
patient have insomnia
Treatment: Insomnia medication and No insomnia medication
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction
- Plain-language title
- Sleeplessness after heart attack procedures and later health outcomesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 18 February 2026